Related references
Note: Only part of the references are listed.Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Mauro Gori et al.
DIABETES CARE (2016)
Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score
M. Woodward et al.
DIABETES OBESITY & METABOLISM (2016)
Change in Novel Filtration Markers and Risk of ESRD
Casey M. Rebholz et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Association of Cardiometabolic Multimorbidity With Mortality The Emerging Risk Factors Collaboration
Emanuele Di Angelantonio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
Kunihiro Matsushita et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus
J. van der Leeuw et al.
HEART (2015)
Identification of Incident CKD Stage 3 in Research Studies
Morgan E. Grams et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
CIRCULATION (2014)
External Validation of the UKPDS Risk Engine in Incident Type 2 Diabetes: A Need for New Type 2 Diabetes-Specific Risk Equations
Christian A. Bannister et al.
DIABETES CARE (2014)
How diabetes risk assessment tools are implemented in practice: A systematic review
Teerapon Dhippayom et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
Anna H. Price et al.
DIABETOLOGIA (2014)
Glycated Hemoglobin Measurement and Prediction of Cardiovascular Disease
Emanuele Di Angelantonio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Changes in Diabetes-Related Complications in the United States, 1990-2010
Edward W. Gregg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States
Meredith C. Foster et al.
AMERICAN HEART JOURNAL (2013)
The ADVANCE cardiovascular risk model and current strategies for cardiovascular disease risk evaluation in people with diabetes
Andre Pascal Kengne
CARDIOVASCULAR JOURNAL OF AFRICA (2013)
Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus
J.-B. Echouffo-Tcheugui et al.
DIABETES & METABOLISM (2013)
Derivation and Validation of a Renal Risk Score for People With Type 2 Diabetes
C. Raina Elley et al.
DIABETES CARE (2013)
Predicting Macro- and Microvascular Complications in Type 2 Diabetes
Shiro Tanaka et al.
DIABETES CARE (2013)
Evaluating incremental values from new predictors with net reclassification improvement in survival analysis
Yingye Zheng et al.
LIFETIME DATA ANALYSIS (2013)
Kidney Disease in People With Diabetes: The Expanding Epidemic
Elizabeth Selvin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes
Meg J. Jardine et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update Foreword
Michael V. Rocco et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Association of C-Reactive Protein With Cardiovascular Disease Mortality According to Diabetes Status Pooled analyses of 25,979 participants from four UK prospective cohort studies
Andre Pascal Kengne et al.
DIABETES CARE (2012)
One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic Kidney Disease
Marjan Alssema et al.
DIABETES CARE (2012)
Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
Andrzej S. Krolewski et al.
DIABETES CARE (2012)
Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus
Diewertje Sluik et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
Lesley A. Inker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD
Akshay S. Desai et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent
Nina P. Paynter et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2011)
Barriers to Routine Risk-Score Use for Healthy Primary Care Patients
Falk Müller-Riemenschneider
ARCHIVES OF INTERNAL MEDICINE (2010)
Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study
Elizabeth Selvin et al.
JOURNAL OF DIABETES (2010)
Predicting the 30-Year Risk of Cardiovascular Disease The Framingham Heart Study
Michael J. Pencina et al.
CIRCULATION (2009)
Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC-Norfolk Cohort
Rebecca K. Simmons et al.
DIABETES CARE (2009)
Cardiovascular risk assessment scores for people with diabetes: a systematic review
P. Chamnan et al.
DIABETOLOGIA (2009)
Prognostic Models With Competing Risks Methods and Application to Coronary Risk Prediction
Marcel Wolbers et al.
EPIDEMIOLOGY (2009)
Heart failure incidence and survival (from the atherosclerosis risk in communities study)
Laura R. Loehr et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Integrating the predictiveness of a marker with its performance as a classifier
Margaret S. Pepe et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: The RENAAL study
William F. Keane et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Overall C as a measure of discrimination in survival analysis:: model specific population value and confidence interval estimation
MJ Pencina et al.
STATISTICS IN MEDICINE (2004)
Prediction of coronary heard disease in middle-ages adults with diabetes
AR Folsom et al.
DIABETES CARE (2003)
UKPDS 60 - Risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine
V Kothari et al.
STROKE (2002)